Abstract:Reversal of Brain Aging Phenotypes. Microinjection of a cocktail containing four metabolites‐ putrescine, glycine, methionine and threonine (one‐carbon‐metabolite induction medium, 1C‐MIM) into the dentate gyrus of old mice results in the partial reversion of brain aging phenotypes. These changes include the reversion of the methylation patterns of specific age‐related chromatin components, RNA transcription changes, increased adult hippocampal neurogenesis, enhanced expression of young‐related synaptic proteins. Most importantly, this treatment also results in significant cognitive improvement. The Izpisua‐Belmonte group identified a cocktail of metabolites that promote partial reprogramming in cultured muscle cells. We tested the effect of brain injection of these metabolites in the dentate gyrus of aged wild‐type mice. The dentate gyrus is a brain region essential for memory function and is extremely vulnerable to aging. A single injection of the cocktail containing four compounds (putrescine, glycine, methionine and threonine) partially reversed brain aging phenotypes and epigenetic alterations in age‐associated genes. Our analysis revealed three levels: chromatin methylation, RNA sequencing, and protein expression. Functional studies complemented the previous ones, showing cognitive improvement. In summary, we report the reversal of various age‐associated epigenetic changes, such as the transcription factor Zic4, and several changes related to cellular rejuvenation in the dentate gyrus (DG). These changes include increased expression of the Sox2 protein. Finally, the increases in the survival of newly generated neurons and the levels of the NMDA receptor subunit GluN2B were accompanied by improvements in both short‐term and long‐term memory performance. Based on these results, we propose the use of these metabolites to explore new strategies for the development of potential treatments for age‐related brain diseases.

Neuron-specific partial reprogramming in the dentate gyrus impacts mouse behavior and ameliorates age-related decline in memory and learning.

In vivo cyclic overexpression of Yamanaka factors restricted to neurons reverses age-associated phenotypes and enhances memory performance

In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice

Partial Reprogramming as a Method for Regenerating Neural Tissues in Aged Organisms

Transcriptomic reprogramming for neuronal age reversal

The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders

Cognitive rejuvenation in old rats by hippocampal OSKM gene therapy

Effect of Neural Stem Cells Transplantation on Protein Expressions of Doublecortin and Nestin in Hippocampal Regions in App/ps1 Mice

Hippocampal rejuvenation by a single intracerebral injection of one‐carbon metabolites in C57BL6 old wild‐type mice

Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming

Role of folate receptor α in the partial rejuvenation of dentate gyrus cells: Improvement of cognitive function in 21-month-old aged mice

Re-activation of neurogenic niches in aging brain

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Therapeutically viable generation of neurons with antisense oligonucleotide suppression of PTB

Reprogramming to Alleviate Alzheimer’s Disease Through Ameliorating Microglial Inflammation and Neuronal Damage

Epigenetic editing of the Dlg4/PSD95 gene improves cognition in aged and Alzheimer's disease mice

In vivo neuron-specific expression of C. elegans reprogramming factor orthologs does not alleviate age-related cognitive decline

Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging

Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation

Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders

Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice